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Solvents are complex chemical mixtures con-
taining many different hydrocarbon types,
such as alkanes, alcohols, ketones, aldehydes,
esters, ethers, and small aromatic molecules,
that evaporate and become incorporated
into environmental air as volatile organic
compounds (VOCs). Although the percent-
age of each chemical in solvent formulations
varies among commercial brands, toluene is
ubiquitously the most abundant ingredient
(Mercado-Calderón 1997). Products used in
many industrial workshops and in the home
contain potentially hazardous solvents.
Therefore, people working in such industries
or at home risk continuous exposure to
VOCs released from solvents.
Toluene is a systemic toxicant that affects
liver, kidney, and the central nervous system
[Agency for Toxic Substances and Disease
Registry (ATSDR) 2000], the last being consid-
ered the main target organ (Byrne et al. 1991).
Toluene biotransformation takes place in the
liver by the cytochrome P450 2E1 (CYP2E1)
isoform, producing hippuric acid, which is
excreted in urine (Nakajima and Wang 1994).
Toluene also up-regulates its own metabolism
by inducing CYP2E1 activity in rat liver and
peripheral lymphocytes (Gonzalez-Jasso et al.
2003). CYP2E1 induction is relevant because
this enzyme activates many xenobiotics to
become ultimate toxicants (Guengerich and
Shimada 1991). In fact, CYP2E1 induction is
the ﬁrst step leading to the development of cer-
tain chemically mediated cancers (Lieber 1997).
Consequently, exposure to toluene in an occu-
pational setting could represent an increased risk
of toxicity. CYP2E1 polymorphisms may also
modulate this condition, although the extent to
which 5´-flanking region RsaI/PstI polymor-
phisms alter induction is not clear (Wormhoudt
et al. 1999).
Because of the signiﬁcant health risks asso-
ciated with high levels of solvent exposure,
routine monitoring of exposed subjects and
their work environment is necessary to ensure
good occupational health and safety condi-
tions. It is thus advisable to perform studies at
multiple levels to elucidate the mechanisms
involved in mediating occupational chemical
exposure effects, and to search for earlier and
more sensitive biomarkers that will improve
occupational safety (Mutti 1999). Accordingly,
several studies have been reported with the aim
of assessing environmental and health condi-
tions of VOC-exposed workers (Apostoli et al.
1982; Wallen 1986); CYP2E1 phenotype
determination in such populations may pro-
vide additional information.
Chlorzoxazone (CHZ) is a centrally act-
ing muscle relaxant drug that has been used
extensively as a selective probe for CYP2E1
phenotyping; this isoform is the main enzyme
involved in its 6-hydroxylation (6OH-CHZ)
in humans (Lucas et al. 1999). However,
because CHZ clinical prescription is no
longer available in Europe and is under revi-
sion in the United States (Lucas et al. 2001),
it should no longer be used as a routine mon-
itoring probe (Tanaka et al. 2003). Therefore,
alternative methods to assay CYP2E1 pheno-
type in vivo are being investigated. Raucy
et al. (1997) reported a relationship between
CYP2E1 activity in peripheral blood lympho-
cyte microsomes and plasma CHZ metabolic
ratio (6OH-CHZ/CHZ quotient; CYP2E1
metabolism indicator) in alcoholic subjects.
This association suggests that peripheral
lymphocytes and liver are regulated similarly
and could be advantageous for monitoring
purposes (Gonzalez-Jasso et al. 2003). Little
information, however, is available about the
effects of environmental VOCs on CYP2E1
regulation in human peripheral lymphocytes.
Consequently, we investigated the association
of toluene exposure with both CYP2E1
mRNA content in peripheral lymphocytes
and CHZ 6-hydroxylation in occupationally
exposed subjects. We further assessed the
contribution of the 5´-flanking region
RsaI/PstI polymorphism in measured
lymphocyte CYP2E1 mRNA content and
CHZ 6-hydroxylation.
Materials and Methods
Study design. A cross-sectional study was per-
formed with print industry workers in Mexico
City. The study population consisted of
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Print workers are exposed to organic solvents, of which the systemic toxicant toluene is a main
component. Toluene induces expression of cytochrome P450 2E1 (CYP2E1), an enzyme
involved in its own metabolism and that of other protoxicants, including some procarcinogens.
Therefore, we investigated the association between toluene exposure and the CYP2E1 response, as
assessed by mRNA content in peripheral lymphocytes or the 6-hydroxychlorzoxazone
(6OH-CHZ)/chlorzoxazone (CHZ) quotient (known as CHZ metabolic ratio) in plasma, and the
role of genotype (5´-ﬂanking region RsaI/PstI polymorphic sites) in 97 male print workers. The
geometric mean (GM) of toluene concentration in the air was 52.80 ppm (10–760 ppm); 54% of
the study participants were exposed to toluene concentrations that exceeded the maximum per-
missible exposure level (MPEL). The GM of urinary hippuric acid at the end of a work shift
(0.041 g/g creatinine) was elevated relative to that before the shift (0.027 g/g creatinine; p < 0.05).
The GM of the CHZ metabolic ratio was 0.33 (0–9.3), with 40% of the subjects having ratios
below the GM. However, the average CYP2E1 mRNA level in peripheral lymphocytes was 1.07
(0.30–3.08), and CYP2E1 mRNA levels within subjects correlated with the toluene exposure ratio
(environmental toluene concentration:urinary hippuric acid concentration) (p = 0.014). Genotype
did not alter the association between the toluene exposure ratio and mRNA content. In summary,
with further validation, CYP2E1 mRNA content in peripheral lymphocytes could be a sensitive
and noninvasive biomarker for the continuous monitoring of toluene effects in exposed persons.
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http://dx.doi.org/ [Online 13 October 2005]103 unrelated male print workers employed as
ﬂat or rotary printing press operators (24%),
operator assistants (33%), ink handlers (22%),
machine maintenance personnel (mechanics
and electricians) (13%), or supervisors (8%).
Workers were exposed to a commercial non-
benzene-containing organic solvent, composed
of a complex mixture of VOCs, of which
toluene and xylene were the main con-
stituents. Inclusion criteria for participants
were 2-fold: a) only clinically healthy males
with normal hepatic function test values were
included, and b) only those not taking drugs
that alter CYP2E1 activity (e.g., aceta-
minophen, isoniazid, disulﬁram, chlormethia-
zole, or chloroquine) were included (Frye and
Branch 2002; Park et al. 1993; Simi and
Ingelman-Sundberg 1999).
Workers were contacted through the
National Coordination of Health at the
Workplace (Instituto Mexicano del Seguro
Social) and received a thorough explanation
of the aims and procedures of this investiga-
tion; participants signed an informed consent
form (response ratio, 85%). Subjects were
directly interviewed by trained personnel in
order to record clinical, occupational, and
sociodemographic characteristics, tobacco and
alcohol consumption, and use of personal
protection equipment. In addition, the body
mass index (BMI) was calculated for each sub-
ject as the quotient of body weight divided by
the square of the height (Brown 1995).
Subjects were instructed to avoid smoking and
alcohol consumption for 5 days before the
sample collection (Plee-Gautier et al. 2001).
The CINVESTAV-IPN Ethical Committee
approved this investigation protocol.
Quantitation of toluene levels in the
environment. Personal monitors measured
toluene environmental levels in the indoor
air of working areas. Each worker wore a
Radiello passive diffusion monitor (code 130;
Fondazione Salvatore Maugeri, Padua, Italy)
placed within the respiratory area, for an 8-hr
work shift. To extract absorbed solvent mole-
cules, 2 mL carbon disulﬁde was applied to the
monitors, and they were placed on the labora-
tory bench for 30 min and given an occasional
shake. Extracts were analyzed by gas chro-
matography/mass spectrometry, using a
Finnigan chromatograph (San Jose, CA, USA)
equipped with a PONA capillary column
(50 m × 0.25 mm inner diameter × 0.25 µm
film thickness; stationary phase, 5% phenyl-
methyl silicone) and a ﬂame ionization detec-
tor (FID). Run conditions were as follows:
initial temperature was 40°C; then the temper-
ature was increased at an initial ramp of
10°C/min to 150°C and a second ramp of
15°C/min to 180°C (2 min). The injector
(splitless mode) temperature was 200°C, the
FID temperature was 250°C, and the carrier
gas (helium 99.998%; Praxair, Mexico City,
Mexico) was sustained at a constant ﬂow rate
of 35 mL/min. We identiﬁed and quantiﬁed
the chemicals present in the extract samples by
comparison with standards (ChemService,
West Chester, PA, USA) (Cocheo 1983).
Biologic sampling. Blood samples were
collected from each subject’s radial vein and
placed in tubes with or without EDTA for
lymphocyte isolation and CHZ metabolism
evaluation or liver function tests (serum),
respectively. Urine samples were obtained at
the beginning and end of an 8-hr work shift
and used to measure hippuric acid levels. Liver
function was assessed in serum by measuring
alanine aminotransferase, aspartate amino-
transferase, and gamma-glutamyl transferase
activities (Bergmeyer and Horder 1980).
Creatinine was measured in urine by the Jaffe
reaction method (Bartels and Bohmer 1972).
Quantitation of urinary hippuric acid.
We measured urinary hippuric acid according
to the recommendations of the National
Institute for Occupational Safety and Health
(NIOSH 1994). Brieﬂy, we acidiﬁed a 1-mL
urine sample by adding 40 µL hydrochloric
acid, saturated the solution with 0.3 g sodium
chloride, and then extracted hippuric acid by
combining the solution with 4 mL ethyl
acetate and shaking the mixture for 5 min.
After centrifugation at 3,000 rpm for 10 min,
the organic layer was evaporated under a
nitrogen stream until dry and then redissolved
in 1 mL distilled water. Recovery percentage
was calculated by addition of a hippuric acid
standard to urine samples; this control calcu-
lation with the standard revealed a 95% mean
recovery rate.
Urine extracts were analyzed by high-per-
formance liquid chromatography (HPLC)
with a Perkin Elmer 235C chromatograph
(PerkinElmer, Norwalk, CT) equipped with a
diode array detector and a 50 µL loop.
Samples were separated in a 250 mm × 5m m
Spherisorb Ps phaseb column packed with 5
µm C18 reversed phase (Phase Separation Inc.,
Norwalk, CT, USA). The mobile phase was a
mixture of acetonitrile and 0.2% glacial acetic
acid in water (10:90 vol/vol) and was main-
tained at a ﬂow of 1 mL/min. The wavelength
setting was 254 nm.
Quantitation of CHZ and 6OH-CHZ in
plasma. After a 12-hr fast, volunteers ingested
a CHZ tablet (500 mg; Barr Laboratories,
Pomona, NY, USA) and gave blood samples
2 hr later. Plasma was separated by centrifuga-
tion at 1,500 rpm for 10 min. CHZ and
6OH-CHZ were measured according to the
methods described by Lucas et al. (1993).
Plasma samples (0.5 mL) were digested
overnight at 37°C with 20 µL Helix pomatia
juice (132,000 units β-glucuronidase/mL;
Sigma Chemical Co., Mexico City, Mexico)
to hydrolyze 6OH-CHZ conjugates. Proteins
were subsequently precipitated by addition of
0.6 N perchloric acid (4 mL). After centrifu-
gation at 3,000 rpm for 10 min, CHZ and
6OH-CHZ were extracted from the super-
natant twice with ethyl acetate (4 mL) by
shaking for 90 min and centrifugation at
3,000 rpm at 4°C for 10 min. The organic
layer was isolated, allowed to evaporate under
a nitrogen stream until dry, and then resus-
pended in 0.5 mL of mobile phase. Recovery
percentage was calculated in bovine serum
samples with added CHZ and 6OH-CHZ
standards that were analyzed simultaneously
with the study samples.
CHZ and 6OH-CHZ levels were meas-
ured by HPLC using a Lambda-Max model
481 chromatograph (Waters Co., Milford,
MA, USA) equipped with an ultraviolet detec-
tor and a 20 µL loop, and compound separa-
tion was carried out using a 250 mm × 5m m
Spherisorb Ps phaseb column, packed with
5µ m  C 18 reversed phase (Phase Separation
Inc.). The mobile phase contained acetoni-
trile, 0.5% glacial acetic acid, and water
(30:70 vol/vol) and was maintained at a ﬂow
rate of 1 mL/min. The wavelength setting was
287 nm. This procedure achieved a 65%
mean recovery rate for CHZ and 6OH-CHZ,
and the CHZ metabolic ratios reported were
calculated.
Evaluation of peripheral lymphocyte
CYP2E1 mRNA content. Isolation of total
RNA. Lymphocytes were separated from
7 mL of whole blood as described by Boyum
(1968). Brieﬂy, blood diluted 1:1 with saline
solution was layered over 5 mL Lymphoprep
(Nycomed Pharma AS, Oslo, Norway). After
centrifugation at 1,600 rpm for 25 min at
25°C, we transferred the cell interface to a new
tube, washed it twice with saline solution, and
then centrifuged it at 1,200 rpm for 10 min at
room temperature. Finally, the supernatant
was discharged, and cells were prepared for
RNA extraction treatment. Total RNA was
extracted using TRIzol reagent (Gibco BRL,
Life Technologies, Rockville, MD, USA) fol-
lowing the manufacturer’s instructions.
Extracted RNA samples were suspended in
diethylpyrocarbonate-treated water (20 µL).
Total RNA was spectrophotometrically quanti-
ﬁed, and its integrity was visualized by electro-
phoresis on 1.5% agarose gels stained with
ethidium bromide.
Preparation of standard RNA. A set of
primers was designed based on the human
CYP2E1 cDNA sequence (GenBank acces-
sion number NM000773; National Center
for Biotechnology Information, Bethesda,
MD, USA) to amplify a 443-bp fragment of
the CYP2E1 cDNA. The forward primer
CYP2E1F (5´-ACAGGGACAGGGGAAT-
CAT-3´) is located at the junction of exons 2
and 3, and the reverse primer CYP2E1R
(5´-TGGGGTCCAGAGATTGATG-3´)
is located within exon 5. Using modified
Toluene induces CYP2E1 mRNA in lymphocytes
Environmental Health Perspectives • VOLUME 114 | NUMBER 4 | April 2006 495versions of these primers, we constructed a
standard RNA (recRNA) of the same length
and sequence as endogenous CYP2E1
mRNA, except for a 71-bp deletion in the
middle of the sequence. Construction of this
competitor was accomplished in two steps. In
the ﬁrst step, primers T7CYP2E1 (5´-TAAT-
ACGACTCACTATAGGACAGGGA-
CAGGGGAATCAT-3´) and recRNA
(5´-TGGGGTCCAGAGATTGATGCAGG-
CAAGTAGTGTAGAAAG-3´) were used to
amplify a cDNA from human peripheral blood
lymphocytes. Primer T7CYP2E1 contains the
T7 promoter sequence at the 5´-end of primer
CYP2E1F (underlined sequence), and primer
recRNA corresponds to CYP2E1R with the
exception of a mismatching stretch of 20 bp
located at the 3´-end (underlined sequence). In
the human CYP2E1 cDNA sequence, the
20-bp stretch maps 98 bp upstream from the
CYP2E1R sequence, but in the recRNA
primer both sequences were linked together to
allow the further generation of the deleted
polymerase chain reaction (PCR) fragment
(Figure 1). The PCR product was purified
with a column (Freeze ’N Squeeze DNA gel
extraction spin column; BioRad Laboratories,
Hercules, CA, USA). In the second step,
recRNA derived from the PCR fragment con-
taining the T7 promoter sequence was pre-
pared by in vitro transcription with a T7
Transcription Kit (Roche Diagnostics GmbH,
Mannheim, Germany), according to the man-
ufacturer’s instructions. The recRNA was sub-
sequently treated with RNase-free DNase
(Boehringer Mannheim, Mannhein, Germany)
to remove DNA template. recRNA was quan-
tiﬁed by measuring its absorbance at 260 nm.
Quantitative reverse transcriptase
(RT)-PCR. Endogenous RNA and recRNA
were co-reverse transcribed and amplified
simultaneously. Reverse transcription reactions
were performed in a final volume of 21 µL
containing 16 mM Tris-HCl (pH 8.4),
40 mM KCl, 0.4 mM dithiothreitol, 4 mM
MgCl2, 0.4 mM of each deoxynucleotide
triphosphate, 0.5 µg oligo(dT), 40 U recombi-
nant ribonuclease inhibitor RNaseOUT
(Invitrogen, Carlsbad, CA, USA), and variable
amounts of cellular RNA and recRNA. Sample
solutions were incubated at 65°C for 10 min,
42°C for 50 min, and 70°C for 15 min. Fifty
units of Superscript II reverse transcriptase was
then added to each sample, and the samples
were incubated at 42°C for 50 min and 70°C
for 15 min. The reaction was terminated by
rapid chilling on ice and by adding 4 U
Escherichia coli RNase H (Invitrogen). The
cDNA samples were amplified with primers
CYP2E1F and CYP2E1R in 25 µL PCR
buffer (100 ng of each primer, 1 U Taq poly-
merase, 200 mM Tris-HCl, pH 8.4, 500 mM
KCl, 50 mM MgCl2, and 0.2 mM dNTP
mixture), using the following PCR conditions:
an initial denaturing step at 95°C for 5 min
followed by 37 cycles of amplification that
consisted of a denaturing step at 95°C for
30 sec, an annealing step at 56°C for 30 sec,
and an extension step at 72°C for 30 sec. The
Mendoza-Cantú et al.
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Figure 1. Schematic representation of the CYP2E1 gene showing the polymorphism location and the design
of the recRNA. For the genomic structure, exons, indicated by boxes, are numbered, and introns are repre-
sented by horizontal lines. The arrow indicates the transcription start site, and the RsaI/PstI polymorphism
sites are denoted. To amplify the region of the CYP2E1 gene encompassing exons 2–5, we used forward
primer T7CYP2E1 on the junction of exons 2–3 and reverse primer RecRNA in exon 5. The presence of the
T7 promoter sequence at the 5´ end of the forward primer enabled the recRNA to be produced by in vitro
transcription. Cellular RNA and recRNA were co-reverse transcribed and amplified simultaneously with
the CYP2E1F and CYP2E1R primers. Because the 20 bp stretch incorporated at the 3´ end of the primer
RecRNA (thin line on standard) is complementary to primer CYP2E1, the RT-PCR reaction yielded products
of 453 bp from the cellular RNA and of 382 bp from the recRNA. Both PCR products had the same DNA
sequence, except for the 71 bp deletion in the middle of the standard fragment.
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Figure 2. Reliability of the competitive RT-PCR assay for CYP2E1 transcript. (A) A ﬁxed amount of human
lymphocyte total RNA (5 µg) was incubated with decreasing amounts of recRNA (lane 1, 1 ng; lane 2, 100 pg;
lane 3, 10 pg; lane 4, 1 pg; lane 5, 100 fg; lane 6, 10 fg; lane 7, 1 fg; lane 8, without recRNA. The expected PCR
products of 453 and 382 bp correspond to endogenous CYP2E1 mRNA and recRNA, respectively. (B) A ﬁxed
amount of recRNA (1 pg) was incubated with decreasing amounts of human lymphocyte total RNA. Lane 1,
10 µg; lane 2, 7.5 µg; lane 3, 5 µg; lane 4, 2.5 µg; lane 5, 1 µg; lane 6, without RNA. (C) Representative gel of
the competitive RT-PCR assay showing the CYP2E1 mRNA expression of different subjects (5 µg of total
RNA and 10 pg of recRNA; lanes 1–5). Abbreviations: –, control with RNA sample omitted; M, DNA ladder.
Table 1. Anthropometric characteristics and habits
of the study population.
Variable Frequency or value
No. 97
Age (years)a 34.2 ± 9.8
(18–63)
Years employeda 3.5 ± 1.6
(1–9)
BMI (kg/m2)a 26.98 ± 4.15
(20.38–40.03)
Smoking status (%)b
Nonsmoker 42 (43)
Smoker 55 (57)
Drinking status (%)
Never 8 (8)
Seldom 79 (82)
Frequent 9 (10)
aExpressed as mean ± SD (range). bExpressed as number
of individuals (percentage of population). reaction was terminated with a ﬁnal extension
step at 72°C for 5 min. All reactions were car-
ried out in a Thermocycler GeneAmp PCR
System 2400 (Applied Biosystems, Foster City,
CA, USA). The RT-PCR reaction yielded a
453 bp fragment from endogenous RNA and a
382 bp fragment from recRNA (Figure 2).
The CYP2E1 mRNA ratio was obtained by
dividing the intensity of the endogenous
mRNA band by the intensity of recRNA band.
DNA sequencing. To verify the authentic-
ity of cellular and standard PCR products, they
were sequenced in an ABI PRISM 310 Genetic
Analyzer using the ABI PRISM Big Dye DNA
sequencing kit (Applied Biosystems). 
CYP2E1 genotype. CYP2E1 genotype was
assessed by restriction fragment length poly-
morphism analysis for the 5´-ﬂanking region
RsaI/PstI polymorphic sites (Figure 1),
according to the method described by
Hayashi et al. (1991).
Statistical analysis. Differences between ini-
tial and ﬁnal hippuric acid concentrations were
compared by Student’s t-test. Log transforma-
tions improved normality for CYP2E1 activity
and urinary hippuric acid concentrations.
Simple and multiple linear regression analyses
were carried out to determine whether there
were any associations between toluene expo-
sure and CYP2E1 phenotype (enzymatic
activity or mRNA content). These relation-
ships were stratiﬁed by RsaI/PstI polymorphic
site alleles. Multiple regression models were
adjusted by age, BMI (classified as normal,
overweight, and obesity), current drug con-
sumption (categorized as yes or no), smoking
habit (smokers or nonsmokers), and alcohol
consumption (ranked as never, < 1 serving/
week; seldom, 1 to 2 servings/week; frequent,
> 2 servings/week). All statistical analyses
were conducted using the STATA 8.0 soft-
ware package (Stata Corporation, College
Station, TX, USA).
Results
Demographic and health characteristics of the
study population. Among 103 male workers,
6 subjects were excluded because of abnormal
liver function. The remaining 97 subjects had
a mean age of 34.2 years (range, 18–63 years)
and a mean employment time of 3.5 years
(range, 1–9 years). The BMI data indicated
that 70% of the subjects exhibited some
degree of obesity. In addition, 55% of the
study subjects were smokers, 92% of them
declared some degree of alcohol consump-
tion, and 10% considered themselves to be
frequent drinkers. Table 1 summarizes the
anthropometric characteristics and habits of
the study population.
Environmental toluene and urinary hip-
puric acid levels. Table 2 summarizes the
indoor air toluene concentrations to which the
workers were exposed in the print workshop
and the levels of toluene exposure biologic
markers. Air toluene concentrations moni-
tored individually for a work shift had a geo-
metric mean (GM) of 52.80 ppm (range,
10–760 ppm). Thus, 54% of the subjects stud-
ied were exposed to toluene levels that exceeded
the 50 ppm maximal permissible exposure level
(MPEL) (NOM-010-STPS-1999 2000).
The GM of the urinary hippuric acid at
the beginning and the end of a work shift were
0.027 and 0.041 g/g creatinine, respectively.
Both values were below the maximal biologic
permissible level (MBPL) of 2.5 g/g creatinine
(NOM-047-SSA1-1993 1996). However,
these data represent a 48% increase in urinary
hippuric acid GM from the beginning to the
end of the shift (p < 0.05)  (Figure 3). This
increase is consistent with the occurrence of
active toluene absorption and biotransforma-
tion during the work shift.
CY2E1 mRNA associations with toluene,
hippuric acid, and the toluene exposure ratio.
In the present study, we assessed toluene expo-
sure in two steps. First, toluene levels in work
area air and hippuric acid levels in urine were
measured for each subject, and these data were
individually associated with the subject’s
CYP2E1 mRNA data. These comparisons
yielded statistically signiﬁcant but opposite cor-
relations. That is, environmental toluene corre-
lated positively with CYP2E1 mRNA levels
(r2 = 0.062, β = 0.011, p = 0.029; n = 76),
whereas urinary hippuric acid levels corre-
lated negatively with CYP2E1 mRNA levels
(r2 = 0.065, β = –4.120, p = 0.027; n = 71).
This dissociation may be due to the capacity of
toluene to induce CYP2E1 mRNA expression,
whereas hippuric acid reﬂects toluene disposi-
tion. Therefore, we conducted further analysis
with the toluene exposure ratio, which was cal-
culated as the quotient of each individual’s
environmental toluene concentration exposure
divided by his measured urine hippuric acid
concentration. CYP2E1 mRNA level and the
toluene exposure ratio showed a statistically
signiﬁcant relationship (p < 0.05) (Figure 4).
Using this ratio enabled each subject’s exposure
to be more accurately described, bearing in
mind the variability between internal and
external conditions among workers and allow-
ing us to normalize the individual differences
observed in toluene metabolism. Such inter-
individual differences are likely to result from
several factors: a) differing toluene exposures
that lead to different hippuric acid production;
b) a competitive inhibition of toluene metabo-
lism by other VOCs, which was greater in
workers exposed to high toluene concentra-
tions; c) differing metabolic statuses, depend-
ing upon individual genetic characteristics and
the extent of CYP2E1 induction; and d) possi-
ble development of a tolerance to toluene, as
has been described for other CYP2E1 sub-
strates (Shayiq et al. 1999). The GM for the
toluene exposure ratio was 0.122, ranging
between 0.007 and 3.366 (Table 2).
CYP2E1 phenotype and genotype in the
study population. CHZ biotransformation is
related to CYP2E1 activity (Lucas et al.
1999), which is induced by toluene (Uaki
et al. 1995). However, CHZ metabolism can
be competitively inhibited by other contami-
nants in an occupational setting (Lucas et al.
1999); such effects will be reflected in the
CHZ metabolic ratio. The GM of the CHZ
metabolic ratio was 0.33 (0–9.3); however,
40% of the study population values were
< 0.3. On the other hand, blood peripheral
lymphocyte CYP2E1 mRNA content was
1.07 with a range of 0.03–3.08 (Table 2).
Toluene induces CYP2E1 mRNA in lymphocytes
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Table 2. Environmental and biologic parameters in
toluene-exposed subjects from the print industry.
Variable No. GM (range)
Environmental toluene (ppm) 94 52.80 (10–760)
Urinary hippuric acid
(g/g creatinine) 90
Beginning of the shift 0.027 (ND–0.167)
End of the shift 0.041* (ND–0.177)
Toluene exposure ratioa 84 0.122 (0.007–3.366)
CHZ metabolic ratiob 93 0.33 (0–9.3)
CYP2E1 mRNA contentc 79 1.07 (0.30–3.08)
ND, not detected.
aToluene exposure ratio (individual environmental toluene
concentration/hippuric acid concentration quotient). bCHZ
metabolic ratio (6OH-CHZ/CHZ quotient). cExpressed as
average value. *Statistically significant difference from
concentrations at the beginning of the work shift (p < 0.05).
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Figure 3. Effect of environmental toluene concen-
tration on urinary hippuric acid concentration eval-
uated by simple linear regression analysis (n = 84).
y = 0.0076x – 0.0133; r2 = 0.049; p = 0.041.
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Figure 4. Relationship between toluene exposure
ratio and CYP2E1 mRNA content (n = 67). y =
0.0929x + 1.320; r2 = 0.0854; p = 0.016.Genotype frequencies for the RsaI/PstI
polymorphisms were reported previously
(Mendoza-Cantú et al. 2003). Briefly, 60
native homozygous (c1/c1), 34 heterozygous
(c1/c2), and 3 homozygous (c2/c2) subjects
were found. These genotype frequencies are in
accordance with the Hardy-Weinberg equilib-
rium model (Klug and Cummings 2000).
The stratification of CYP2E1 phenotype
parameters per genotype showed the following
values: mRNA content c1/c1: GM = 1.0645;
range = 2.069–0.304; c1/c2, GM = 1.056,
range = 2.123–0.477; c2/c2, GM = 1.319,
range = 1.708–1.153. The CHZ metabolic
ratios for each genotype were as follows: c1/c1,
GM = 0.327, range = 2.362–0.0023; c1/c2,
GM = 0.367, range = 1.597–0.0310; c2/c2,
GM = 0.430, range = 2.287–0.117. There was
no apparent influence of genotype on the
measured mRNA content levels and CHZ
metabolic ratios.
Relationships between toluene exposure
and CYP2E1 phenotype. We found a correla-
tion between the toluene exposure ratio and
CYP2E1 mRNA content (r2 = 0.0854, β =
0.0929, p = 0.016; n = 67) (Figure 4).
However, the CHZ metabolic ratio did not
correlate with either the toluene exposure ratio
(r2 = 0.237, β = –0.007, p = 0.744; n = 84) or
CYP2E1 mRNA content (r2 = 0.215,
β = –0.026, p = 0.686; n = 78) (Table 3).
Obesity, age, and smoking, as well as con-
sumption of alcohol and certain drugs, have
been shown to modulate CYP2E1 expression
(Bebia et al. 2004; Benowitz et al. 2003; Frye
and Branch 2002; Lieber 2004; Park et al.
1993; Simi and Ingelman-Sundberg 1999).
Additionally, the use of personal protective
equipment can reduce exposure to toluene
and other VOCs. To address their potential
confounding effect on CYP2E1 expression by
toluene occupational exposure, we performed
a linear regression analysis (simple and multi-
ple) by adjusting for the variables mentioned
above. None of them had any appreciable
effect on the relationship between the toluene
exposure ratio and mRNA content (Table 4).
Relation between toluene exposure ratio
and CYP2E1 mRNA content stratified by
genotype. The relationship between toluene
exposure ratio and CYP2E1 mRNA content
was stratiﬁed according to RsaI/PstI polymor-
phisms, but this association was not modiﬁed
by genotype in a slope analysis.
Discussion
We investigated the effects of toluene expo-
sure on expression of the CYP2E1 phenotype
by measuring CYP2E1 mRNA induction in
peripheral lymphocytes and CHZ metabolism
in workers exposed to organic solvents and
then determining whether these mRNA con-
tent and CHZ metabolic data were associated
with genotype.
Toluene in the work environment. Toluene
exposure in the present group of subjects
(GM = 52.80 ppm) was to similar to the lower
limit reported for toluene exposure in a previ-
ous study of workers from 25 Mexican compa-
nies (52.5–931 ppm) in which the workers
routinely handled organic solvents, paints, and
varnishes (Madrigal-Bujaidar et al. 1996).
Regrettably, both studies revealed environ-
mental toluene concentrations that exceeded
the limits set by Mexican regulations (NOM-
010-STPS-1999 2000). Indeed in the present
study, 54% of our study population was above
the toluene MPEL. Therefore, stricter regula-
tions should be implemented to ensure safe
conditions in the occupational environment.
Hippuric acid content in urine. Hippuric
acid has been used extensively as a toluene
exposure biomarker, but this metabolite may
occur in the diet, that is, via some fruits and
food preservatives (Kawamoto et al. 1996). In
this study, a statistically signiﬁcant increase in
hippuric acid concentrations during the work
shift (48%) demonstrated active absorption
and biotransformation of toluene by exposed
workers. Despite the high toluene levels in air,
the hippuric acid concentrations remained
below the MBPL. This apparent inconsis-
tency between the environmental and the bio-
logic data leads to a disagreement between the
MPEL and MBPL. Thus, an environmental
exposure to toluene of 50 ppm for an 8 hr
work shift resulted in a urinary hippuric acid
concentration of < 2.5 g/g creatinine. De
Bruin (1980) studied a group of volunteers
exposed to 100 ppm toluene for 8 hr (twice
the MPEL), but this high level of exposure
produced a relatively low urinary hippuric
acid excretion of 1.2 g/g creatinine. Although
toluene is one of the main constituents of the
organic solvent used in the print industry,
these mixtures also contain many other VOCs
that may be potential CYP2E1 substrates that
may competitively inhibit its activity, as has
been described for other chemicals (Campo
et al. 1998; Tardif et al. 1993; Uaki et al.
1995).
Toluene effects on CYP2E1 phenotype.
Various factors, including exposure to certain
xenobiotics, can induce CYP2E1 expression
and thereby result in an increase in its meta-
bolic activity. Such induction could be a risk to
the health of persons exposed to CYP2E1 pro-
toxicant substrates; thus, CYP2E1 expression
demands close monitoring in those individuals.
The CHZ metabolic ratio. Most of our
subjects showed small CHZ metabolic ratios
(40% had ratios < 0.3), indicating a very low
CHZ biotransformation rate, a finding that
may be attributable to competitive inhibition
of CHZ metabolism by VOCs. We did not
detect significant differences between the
toluene exposure ratio and CHZ metabolic
ratio, or between CHZ metabolism and
mRNA content. Lucas et al. (1999) reported
a decreased CHZ metabolic ratio in shoe-
makers exposed to glue and suggested that
there may be metabolic competition between
CHZ and the organic chemicals present in
the solvent’s emissions. Furthermore,
Ernstgård et al. (1999) found evidence that
coexposure to acetone and CHZ or to toluene
and CHZ increased plasma concentrations of
both the organic chemicals and CHZ in
human males, indicating that there was meta-
bolic competition as a result of these inter-
actions. In addition, Powell et al. (1998)
found that human livers showed no correla-
tion between mRNA levels and CYP2E1 pro-
tein content and p-nitrophenol and CHZ
hydroxylation activity. Likewise, Sumida et al.
(1999) reported no correlation between
CYP2E1 mRNA level and CHZ hydroxy-
lation in human liver biopsies. Thus, these
lack of associations suggests that the CHZ
metabolic ratio may not be an appropriate
biomarker for toluene exposure when evalu-
ated directly at the occupational site.
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Table 3. Multiple regression analysis modeling the effects of toluene exposure on CYP2E1 phenotype and
of CYP2E1 mRNA content on CHZ metabolic ratio.
mRNA content CHZ metabolic ratio
Variable β r2 95% CI n β r2 95% CI n
Toluene exposure ratio 0.099 0.202 0.020 to 0.177 67 –0.007 0.237 –0.055 to 0.040 84
mRNA content –0.026 0.215 –0.159 to 0.105 78
CI, confidence interval. Models were adjusted for alcohol and drug consumption, smoking habit, BMI, use of personal
protection equipment, and age.
Table 4. Effects of potential confounders on CYP2E1 mRNA content.
Variable β r2 95% CI
Alcohol consumption –0.034 0.0267 –0.081 to 0.012
Recent alcohol consumption –0.025 0.0085 –0.086 to 0.036
Smoking habit –0.125 0.0295 –0.289 to 0.037
Current drug consumption –0.003 0.0002 –0.063 to 0.056
BMI 0.128 0.0451 –0.005 to 0.263
Use of protection equipment 0.024 0.0175 –0.017 to 0.065
Age 0.000 0.0003 –0.009 to 0.010
CI, conﬁdence interval of multiple regression analysis.CYP2E1 mRNA induction. The associa-
tions of peripheral lymphocyte CYP2E1
mRNA content with environmental toluene or
urinary hippuric acid were statistically signiﬁ-
cant. Furthermore, the peripheral lymphocyte
CYP2E1 mRNA with the toluene metabolic
ratio, a parameter that considers both exposure
and disposition, was also signiﬁcant.
The observed correlation between CYP2E1
mRNA induction and the toluene metabolic
ratio suggests that CYP2E1 mRNA content is
a much more sensitive probe than is the CHZ
metabolic ratio. Moreover, CYP2E1 mRNA
content is a safe, noninvasive test, for which
samples can be obtained on site, and its expres-
sion in human peripheral lymphocytes appears
to be regulated by the same factors as those
affecting the liver (Raucy et al. 1997).
The CYP2E1 response we observed in
this study demonstrated that toluene exposure
affects CYP2E1 mRNA content, but more
studies on toluene toxicity are needed to fully
characterize the mechanism of induction.
Other chemicals, such as ethanol, can regulate
CYP2E1 activity by altering protein stabiliza-
tion without affecting transcriptional activity
(Roberts et al. 1995). Ethanol has also been
shown to increase CYP2E1 gene expression at
high doses (> 300 mg/dL blood) (Badger
et al. 1993). Finally, CYP2E1 genotype strati-
fication did not modify the association
between toluene exposure and mRNA con-
tent in peripheral lymphocytes.
In conclusion, our results suggest that
CYP2E1 mRNA content may be a useful bio-
marker of physiologic effects in humans
exposed to toluene. The mRNA response is
the ﬁrst step after its modulation and may not
be affected by other factors that modify
CYP2E1 enzyme activity, as has been sug-
gested to be a complicating factor for CHZ
metabolism. However, further studies are
needed to fully characterize and validate the
use of CYP2E1 mRNA content for health
surveillance purposes.
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CORRECTION
Values for the correlation between the
toluene exposure ratio and CYP2E1 mRNA
content were incorrect in the manuscript
published online. They have been corrected
here.
Toluene induces CYP2E1 mRNA in lymphocytes
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